• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

对新型强效促性腺激素释放激素拮抗剂西曲瑞克的激素反应。

Hormonal responses to the new potent GnRH antagonist Cetrorelix.

作者信息

Klingmüller D, Schepke M, Enzweiler C, Bidlingmaier F

机构信息

Department of Clinical Biochemistry, University of Bonn, Germany.

出版信息

Acta Endocrinol (Copenh). 1993 Jan;128(1):15-8. doi: 10.1530/acta.0.1280015.

DOI:10.1530/acta.0.1280015
PMID:8447189
Abstract

GnRH antagonists, unlike the GnRH agonists, immediately suppress gonadotropins and testosterone secretion without initial stimulatory effect. We report here on a single-dose study with the new GnRH antagonist Cetrorelix (Ac-D-Nal(2)1, D-Phe(4C1)2, D-Pal3, D-Cit6, D-Alal0) in 25 normal men. The study involved five different dose groups (0.25, 0.5, 1.0, 1.5 or 3.0 mg) and subjects were observed over a 40 h period. Five men served as controls. Serum levels of LH, FSH and testosterone decreased rapidly with a dose-related decline for testosterone of 25%, 24%, 41%, 53% and 72%, respectively, for testosterone within the first 8 h of antagonist administration. All effects were reversible and no serious side effects were observed. Thus, this GnRH antagonist is active in men even in small doses and could become a new therapeutic tool for sex hormone-dependent diseases. Cetrorelix seems to have the highest suppressive rate per mg peptide of all other antagonists from the literature, such as Nal-Glu (Ac-D-Nal(2)1, D-Phe(4Cl)2, D-Pal3, Arg5, D-Glu6(AA), D-Alal0), Detirelix (Ac-D-Nal(2)1, D-pCl-Phe2, D-Trp3, D-hArg(Et2)6, D-Alal0) or 4F (Ac-delta 3Prol, 4F-D-Phe2, D-Trp3,6). During the time of suppression after a dose of 3 mg there was an LH and testosterone peak in the early morning coinciding with the testosterone peak in untreated men. The GnRH antagonist seems to unmask the circadian rhythm of LH secretion.

摘要

促性腺激素释放激素(GnRH)拮抗剂与GnRH激动剂不同,它能立即抑制促性腺激素和睾酮分泌,且无初始刺激作用。我们在此报告一项针对25名正常男性使用新型GnRH拮抗剂西曲瑞克(Ac-D-Nal(2)1, D-Phe(4C1)2, D-Pal3, D-Cit6, D-Alal0)的单剂量研究。该研究包括五个不同剂量组(0.25、0.5、1.0、1.5或3.0毫克),并对受试者进行了40小时的观察。五名男性作为对照。在给予拮抗剂后的前8小时内,促黄体生成素(LH)、促卵泡生成素(FSH)和睾酮的血清水平迅速下降,睾酮下降与剂量相关,分别为25%、24%、41%、53%和72%。所有作用均可逆,未观察到严重副作用。因此,这种GnRH拮抗剂即使小剂量在男性中也有活性,可能成为治疗性激素依赖性疾病的新治疗工具。从文献来看,西曲瑞克每毫克肽的抑制率似乎高于所有其他拮抗剂,如那法瑞林(Nal-Glu,Ac-D-Nal(2)1, D-Phe(4Cl)2, D-Pal3, Arg5, D-Glu6(AA), D-Alal0)、地来瑞林(Detirelix,Ac-D-Nal(2)1, D-pCl-Phe2, D-Trp3, D-hArg(Et2)6, D-Alal0)或4F(Ac-delta 3Prol, 4F-D-Phe2, D-Trp3,6)。在给予3毫克剂量后的抑制期内,清晨出现LH和睾酮峰值,与未治疗男性的睾酮峰值一致。这种GnRH拮抗剂似乎揭示了LH分泌的昼夜节律。

相似文献

1
Hormonal responses to the new potent GnRH antagonist Cetrorelix.对新型强效促性腺激素释放激素拮抗剂西曲瑞克的激素反应。
Acta Endocrinol (Copenh). 1993 Jan;128(1):15-8. doi: 10.1530/acta.0.1280015.
2
Comparison of the antigonadotropic activity of three GnRH antagonists (Nal-Glu, Antide and Cetrorelix) in a non-human primate model (Macaca fascicularis).三种促性腺激素释放激素拮抗剂(那法瑞林-谷氨酸、安替肽和西曲瑞克)在非人灵长类动物模型(食蟹猴)中的抗促性腺活性比较。
Andrologia. 1993 May-Jun;25(3):141-7. doi: 10.1111/j.1439-0272.1993.tb02698.x.
3
Effective suppression of luteinizing hormone and testosterone by single doses of the new gonadotropin-releasing hormone antagonist cetrorelix (SB-75) in normal men.新型促性腺激素释放激素拮抗剂西曲瑞克(SB - 75)单剂量对正常男性促黄体生成素和睾酮的有效抑制作用
J Clin Endocrinol Metab. 1992 Aug;75(2):393-8. doi: 10.1210/jcem.75.2.1639941.
4
Sustained suppression of serum LH, FSH and testosterone and increase of high-density lipoprotein cholesterol by daily injections of the GnRH antagonist cetrorelix over 8 days in normal men.在正常男性中,通过每日注射促性腺激素释放激素(GnRH)拮抗剂西曲瑞克,持续8天抑制血清促黄体生成素(LH)、促卵泡生成素(FSH)和睾酮,并增加高密度脂蛋白胆固醇。
Clin Endocrinol (Oxf). 1994 Feb;40(2):241-8. doi: 10.1111/j.1365-2265.1994.tb02475.x.
5
Concordant suppression of serum immunoreactive luteinizing hormone (LH), follicle-stimulating hormone, alpha subunit, bioactive LH, and testosterone in postmenopausal women by a potent gonadotropin releasing hormone antagonist (detirelix).一种强效促性腺激素释放激素拮抗剂(地瑞瑞克)对绝经后妇女血清免疫反应性促黄体生成素(LH)、促卵泡生成素、α亚基、生物活性LH及睾酮的协同抑制作用
J Clin Endocrinol Metab. 1992 Feb;74(2):399-405. doi: 10.1210/jcem.74.2.1370507.
6
Induction of azoospermia in normal men with combined Nal-Glu gonadotropin-releasing hormone antagonist and testosterone enanthate.联合使用那法瑞林-谷氨酸促性腺激素释放激素拮抗剂和庚酸睾酮诱导正常男性无精子症
J Clin Endocrinol Metab. 1992 Aug;75(2):476-83. doi: 10.1210/jcem.75.2.1639948.
7
Suppression of plasma gonadotropins and testosterone in adult male monkeys (Macaca fascicularis) by a potent inhibitory analog of gonadotropin-releasing hormone.促性腺激素释放激素强效抑制类似物对成年雄性猕猴(食蟹猴)血浆促性腺激素和睾酮的抑制作用
J Clin Endocrinol Metab. 1986 Jan;62(1):58-63. doi: 10.1210/jcem-62-1-58.
8
Marked suppression of gonadotropins and testosterone by an antagonist analog of gonadotropin-releasing hormone in men.
Fertil Steril. 1991 Jan;55(1):156-64.
9
Suppression of pituitary-gonadal function by a potent new luteinizing hormone-releasing hormone antagonist in normal men.一种强效新型促黄体生成激素释放激素拮抗剂对正常男性垂体-性腺功能的抑制作用。
J Clin Endocrinol Metab. 1987 May;64(5):931-6. doi: 10.1210/jcem-64-5-931.
10
Hormonal effects of single gonadotropin-releasing hormone antagonist doses in men.
J Clin Endocrinol Metab. 1988 May;66(5):1065-70. doi: 10.1210/jcem-66-5-1065.

引用本文的文献

1
Research advances in drug therapy of endometriosis.子宫内膜异位症药物治疗的研究进展
Front Pharmacol. 2023 Jun 21;14:1199010. doi: 10.3389/fphar.2023.1199010. eCollection 2023.
2
Gonadotropin-Releasing Hormone Antagonists-A New Hope in Endometriosis Treatment?促性腺激素释放激素拮抗剂——子宫内膜异位症治疗的新希望?
J Clin Med. 2023 Jan 28;12(3):1008. doi: 10.3390/jcm12031008.
3
The Effects of Chemical Castration with Degarelix on Bone Turnover: Densitometric and Biomechanics Bone Properties of Male Rats.地加瑞克化学去势对骨转换的影响:雄性大鼠的骨密度和生物力学骨特性
Int J Endocrinol Metab. 2018 Jul 2;16(3):e64038. doi: 10.5812/ijem.64038. eCollection 2018 Jul.
4
Assessment of the luteal phase in stimulated and substituted cycles.刺激周期和替代周期中黄体期的评估。
Facts Views Vis Obgyn. 2009;1(1):30-46.
5
Decapeptyl ameliorates cyclophosphamide-induced reproductive toxicity in male Balb/C mice: histomorphometric, stereologic and hormonal evidences.曲普瑞林改善环磷酰胺诱导的雄性Balb/C小鼠生殖毒性:组织形态计量学、体视学和激素证据
Iran J Reprod Med. 2013 Oct;11(10):791-800.
6
Evaluation of degarelix in the management of prostate cancer.评价地加瑞克在前列腺癌治疗中的应用。
Cancer Manag Res. 2010 Jan 25;2:39-52. doi: 10.2147/cmar.s8841.
7
Comparison between a GnRH agonist and a GnRH antagonist protocol for the same patient undergoing IVF.同一患者接受体外受精时促性腺激素释放激素激动剂方案与促性腺激素释放激素拮抗剂方案的比较。
J Huazhong Univ Sci Technolog Med Sci. 2008 Oct;28(5):618-20. doi: 10.1007/s11596-008-0529-3. Epub 2008 Oct 10.
8
In vivo biodistribution of an androgen receptor avid PET imaging agent 7-alpha-fluoro-17 alpha-methyl-5-alpha-dihydrotestosterone ([(18)F]FMDHT) in rats pretreated with cetrorelix, a GnRH antagonist.一种雄激素受体亲和性正电子发射断层显像剂7-α-氟-17α-甲基-5-α-二氢睾酮([(18)F]FMDHT)在经促性腺激素释放激素拮抗剂西曲瑞克预处理的大鼠体内的生物分布。
Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):379-85. doi: 10.1007/s00259-007-0610-3. Epub 2007 Oct 13.
9
Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.低剂量促黄体生成素释放激素(LHRH)拮抗剂西曲瑞克长期治疗对雄性和雌性大鼠垂体LHRH受体及性腺轴的影响。
Proc Natl Acad Sci U S A. 2004 Apr 6;101(14):4996-5001. doi: 10.1073/pnas.0400605101. Epub 2004 Mar 24.
10
Gonadotropin-releasing hormone antagonists for assisted reproductive techniques: are there clinical differences between agents?用于辅助生殖技术的促性腺激素释放激素拮抗剂:不同药物之间存在临床差异吗?
Drugs. 2004;64(6):563-75. doi: 10.2165/00003495-200464060-00001.